In summary, we propose the underlying mechanism by which, under the influence of ghrelin, low BMI induces neuronal activation and secretion of NPY via GHSR/PKCα/ERK axis, which binds to Y5R on tumor cells, triggering a metabolic switch from glucose to fatty acids, thereby promoting brain metastatic progression (Fig.5K). Here, NPY is linked to neoplasm.